Business & regional news

Month Year

Month Year

Nov 10, 2023

Medtronic announces 12-month study results showing DTM™ spinal cord stimulation programming provides long-term, significant pain relief for indicated chronic back pain patients not eligible for spine surgery

NOVA Study: On-label, prospective, multicenter, randomized controlled trial compared DTM™ SCS to conventional spinal cord stimulation
- Neuromodulation
Oct 4, 2023

Medtronic names Paolo Di Vincenzo president of the Neuromodulation business
- Neuromodulation
Jan 13, 2023

Medtronic enables a commitment to collaboration in continence care between international scientific societies and patient organizations
Jan 10, 2023

Medtronic to highlight sensing-enabled spinal cord stimulation research at 2023 North American Neuromodulation Society meeting
- Neuromodulation
Nov 29, 2022

Esteve and Medtronic are collaborating to address cancer pain patients’ needs
- Neuromodulation
Jun 6, 2022

Medtronic Announces Dr. Ashwini Sharan Joins Neuromodulation Operating Unit As Chief Medical Officer
- Neuromodulation
May 17, 2022

MEDTRONIC ANNOUNCES FIRST IMPLANT IN STUDY TO EVALUATE INVESTIGATIONAL, CLOSED LOOP NEUROSTIMULATOR FOR THE TREATMENT OF CHRONIC PAIN

Prospective study will evaluate the long-term performance of the closed-loop algorithm and overall patient experience with Medtronic’s next generation, rechargeable spinal cord stimulation device
- Neuromodulation

Show per page